Arterial calcification due to CD73 deficiency
Arterial Calcification Due to CD73 Deficiency[edit | edit source]
Arterial calcification due to CD73 deficiency (ACDC) is a rare genetic disorder characterized by the abnormal deposition of calcium in the arteries, particularly affecting the lower extremities. This condition is caused by mutations in the NT5E gene, which encodes the enzyme CD73. CD73 is crucial for the production of adenosine, a molecule that plays a significant role in inhibiting vascular calcification.
Pathophysiology[edit | edit source]
The NT5E gene provides instructions for making the enzyme CD73, which is involved in the conversion of AMP (adenosine monophosphate) to adenosine. Adenosine is a signaling molecule that has various functions, including vasodilation and inhibition of inflammation. In individuals with ACDC, mutations in the NT5E gene lead to a deficiency of CD73, resulting in reduced levels of adenosine. This deficiency disrupts normal vascular function and promotes the deposition of calcium in the arterial walls.
Clinical Features[edit | edit source]
Patients with ACDC typically present with symptoms related to arterial calcification, such as intermittent claudication, pain in the lower limbs, and reduced mobility. The calcification primarily affects the arteries of the lower extremities, but can also involve the hands and feet. The condition is progressive and can lead to significant morbidity due to impaired blood flow.
Diagnosis[edit | edit source]
Diagnosis of ACDC is based on clinical evaluation, imaging studies, and genetic testing. Imaging techniques such as X-rays, CT scans, or MRI can reveal calcification in the arteries. Genetic testing can confirm the diagnosis by identifying mutations in the NT5E gene.
Treatment[edit | edit source]
Currently, there is no cure for ACDC, and treatment focuses on managing symptoms and preventing complications. Therapeutic approaches may include pain management, physical therapy, and surgical interventions to improve blood flow. Research is ongoing to explore potential treatments that target the underlying genetic and biochemical abnormalities.
Related Pages[edit | edit source]
Gallery[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD